The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo dominates 2026 trader focus, with over 5,000 confirmed cases and 2,300+ deaths reported by mid-August across six provinces, outpacing prior DRC epidemics in speed and scale. Rapid community transmission, limited vaccines for this strain, regional conflict, and mobility through mining areas fuel expectations of further spread to neighbors like Uganda (already linked to 20 cases before declaring its cluster over), Rwanda, South Sudan, or others via cross-border movement. One imported case reached France, highlighting low but real global export risk. Upcoming WHO emergency committee updates, contact-tracing improvements, and year-end surveillance will shape whether additional countries report confirmed cases before resolution.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$33,967 Vol.
30 dic 2026
South Sudan
66%
Rwanda
27%
Burundi
31%
United States
24%
Canada
28%
Kenya
53%
India
14%
Republic of the Congo
28%
Nigeria
20%
Ethiopia
51%
Somalia
24%
China
19%
$33,967 Vol.
South Sudan
$2,058 Vol.
66%
Rwanda
$2,128 Vol.
27%
Burundi
$200 Vol.
31%
United States
$10,195 Vol.
24%
Canada
$1,086 Vol.
28%
Kenya
$195 Vol.
53%
India
$732 Vol.
14%
Republic of the Congo
$12,150 Vol.
28%
Nigeria
$25 Vol.
20%
Ethiopia
$65 Vol.
51%
Somalia
$71 Vol.
24%
China
$3,108 Vol.
19%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo dominates 2026 trader focus, with over 5,000 confirmed cases and 2,300+ deaths reported by mid-August across six provinces, outpacing prior DRC epidemics in speed and scale. Rapid community transmission, limited vaccines for this strain, regional conflict, and mobility through mining areas fuel expectations of further spread to neighbors like Uganda (already linked to 20 cases before declaring its cluster over), Rwanda, South Sudan, or others via cross-border movement. One imported case reached France, highlighting low but real global export risk. Upcoming WHO emergency committee updates, contact-tracing improvements, and year-end surveillance will shape whether additional countries report confirmed cases before resolution.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Mercado abierto: May 22, 2026, 12:35 PM ET
Volumen
$33,967Fecha de finalización
31 dic 2026Mercado abierto
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo dominates 2026 trader focus, with over 5,000 confirmed cases and 2,300+ deaths reported by mid-August across six provinces, outpacing prior DRC epidemics in speed and scale. Rapid community transmission, limited vaccines for this strain, regional conflict, and mobility through mining areas fuel expectations of further spread to neighbors like Uganda (already linked to 20 cases before declaring its cluster over), Rwanda, South Sudan, or others via cross-border movement. One imported case reached France, highlighting low but real global export risk. Upcoming WHO emergency committee updates, contact-tracing improvements, and year-end surveillance will shape whether additional countries report confirmed cases before resolution.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volumen
$33,967Fecha de finalización
31 dic 2026Mercado abierto
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo dominates 2026 trader focus, with over 5,000 confirmed cases and 2,300+ deaths reported by mid-August across six provinces, outpacing prior DRC epidemics in speed and scale. Rapid community transmission, limited vaccines for this strain, regional conflict, and mobility through mining areas fuel expectations of further spread to neighbors like Uganda (already linked to 20 cases before declaring its cluster over), Rwanda, South Sudan, or others via cross-border movement. One imported case reached France, highlighting low but real global export risk. Upcoming WHO emergency committee updates, contact-tracing improvements, and year-end surveillance will shape whether additional countries report confirmed cases before resolution.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes